Bullish Moving Averages
8
Bearish Moving Averages
8
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
152.10Today’s High
159.0052W low
74.2052W High
169.00Open Price
156.60Prev. Close
152.8700Volume
1730218.00Value
264498425.66Fundamentals
Market Cap
3925.40
Price to Earnings
14.00
Price to Book Value
1.80
Dividend Yield
1.60
PE to Growth
1.30
Op Revenue TTM
171.43
Net Profit TTM
280.06
Cash From Operating Activity
22.69
Return on Equity %
12.29
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
13 Sep, 2024
39.4
Week
36.4
Month
36.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
154.66
PIVOT
First Resistance
157.21
Second Resistance
161.56
Third Resistance
164.11
First Support
150.31
Second Support
147.76
Third Support
143.41
Relative Strength Index
49.97
Money Flow Index
47.8
MACD
2.81
MACD Signal
4.08
Average True Range
6.81
Average Directional Index
28.87
Rate of Change (21)
8.9
Rate of Change (125)
74.51
Day Commodity Channel Index
-58.7
Day Williams %R
-88.1
BETA
1 Month
0.64
3 Month
0.74
1 Year
1
3 Year
0.53
PRICE CHANGE ANALYSIS
↓ -3.56%
1 Week
Low
High
152.1
161.84
↑ 9.63%
1 Month
Low
High
136.6
169
↑ 47.06%
3 Months
Low
High
100.25
169
↑ 92.05%
6 Months
Low
High
78.1
169
↑ 91.57%
1 Year
Low
High
74.15
169
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 50.97 | 49.46 | 40.15 | 79.01 | 38.24 | 38.07 | 31.91 | 95.45 | 21.84 | 21.72 | 20.50 | 100.49 | 22.35 | |
| Operating Expenses Qtr | 29.62 | 24.13 | 24.80 | 21.53 | 25.54 | 23.32 | 19.70 | 25.92 | 16.21 | 14.61 | 15.31 | 16.62 | 16.52 | |
| Operating Profit Qtr | 19.46 | 23.37 | 13.14 | 9.63 | 10.11 | 12.78 | 9.84 | 10.46 | 4.92 | 2.79 | 3.30 | 2.47 | 3.86 | |
| EBIDT Qtr Cr | 21.35 | 25.33 | 15.35 | 57.48 | 12.70 | 4.14 | 12.21 | 69.53 | 5.63 | 7.12 | 5.20 | 83.87 | 5.83 | |
| Depreciation Qtr | 2.41 | 1.38 | 2.57 | 1.77 | 1.74 | 1.61 | 1.60 | 1.58 | 1.57 | 1.31 | 1.09 | 1.06 | 1.04 | |
| Net Profit Qtr | 16.84 | 20.68 | 11.29 | 51.43 | 9.48 | 4.29 | 10.45 | 60.90 | 3.63 | 4.62 | 3.95 | 73.40 | 3.75 | |
| Basic EPS Qtr | 0.66 | 0.81 | 0.44 | 2.00 | 0.37 | 0.17 | 0.41 | 2.37 | 0.14 | 0.18 | 0.15 | 2.86 | 0.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 206.87 | 187.27 | 165.06 | 82.27 | 167.16 | |
| Operating Expenses Annual Cr | 96.00 | 85.15 | 63.06 | 61.57 | 69.97 | |
| Operating Profit Annual | 56.25 | 38.01 | 12.92 | 10.73 | 3.72 | |
| Operating Profit Margin Annual % | 27.19 | 20.29 | 7.82 | 13.04 | 2.23 | |
| Total Expenses Annual Cr | 104.15 | 91.67 | 67.79 | 65.75 | 73.48 | |
| EBIDT Annual Cr | 110.86 | 102.12 | 102.01 | 20.70 | 97.19 | |
| EBIDT Annual margin % | 53.59 | 54.53 | 61.80 | 25.16 | 58.14 | |
| Depreciation | 7.46 | 6.36 | 4.50 | 3.91 | 3.23 | |
| PAT Before ExtraOrdinary Items Annual Cr | 92.89 | 79.27 | 85.71 | 13.36 | 93.55 | |
| Net Profit Annual | 92.89 | 79.27 | 85.71 | 13.36 | 93.55 | |
| Basic EPS Annual | 3.62 | 3.09 | 3.34 | 0.52 | 3.64 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 808.76 | 828.99 | 1013.85 | 826.82 | 483.10 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 47.93 | 38.12 | 63.45 | 51.24 | 5.87 | |
| Total Current Liabilities Annual Cr | 89.18 | 81.04 | 66.89 | 58.39 | 45.30 | |
| Total Capital Plus Liabilities Annual Cr | 945.87 | 948.14 | 1144.19 | 936.45 | 534.28 | |
| Fixed Assets Annual | 366.93 | 318.28 | 293.92 | 266.97 | 228.11 | |
| Total Non Current Assets Annual | 812.35 | 780.99 | 1003.96 | 836.84 | 371.69 | |
| Total Current Assets Annual | 133.52 | 167.15 | 140.23 | 99.62 | 162.59 | |
| Total Assets Annual | 945.87 | 948.14 | 1144.19 | 936.45 | 534.28 | |
| Contingent Liabilities plus Commitments Annual Cr | 39.37 | 54.56 | 54.62 | 55.92 | 16.89 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 25.33 | 34.70 | -21.87 | -212.58 | 6.12 | |
| Cash from Investing Activity Annual | 22.60 | 11.29 | 22.66 | 196.20 | 56.79 | |
| Cash from Financing Annual Activity | -47.77 | -46.08 | -5.66 | -35.01 | -7.04 | |
| Net Cash Flow Annual | 0.16 | -0.09 | -4.86 | -51.40 | 55.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 31.50 | 32.28 | 39.48 | 32.20 | 18.81 | |
| ROE Annual % | 11.48 | 9.56 | 8.45 | 1.61 | 19.36 | |
| ROCE Annual % | 12.07 | 11.04 | 9.05 | 1.91 | 19.21 | |
| Total Debt to Total Equity Annual | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 72.81 | 82.91 | 134.26 | 28.62 | 131.88 |
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 52.74 | 51.08 | 41.55 | 80.15 | 39.47 | 39.16 | 33.05 | 96.50 | 22.79 | 22.64 | 21.06 | 100.92 | 22.78 | |
| Operating Expenses Qtr | 30.37 | 24.90 | 27.64 | 22.12 | 25.96 | 23.68 | 20.17 | 26.37 | 16.66 | 15.31 | 15.51 | 16.72 | 16.74 | |
| Operating Profit Qtr | 20.41 | 24.15 | 11.68 | 10.16 | 10.88 | 13.44 | 10.44 | 11.05 | 5.43 | 2.92 | 3.64 | 2.79 | 4.09 | |
| EBIDT Qtr Cr | 22.37 | 26.18 | 13.91 | 58.03 | 13.51 | 4.87 | 12.88 | 70.13 | 6.13 | 7.32 | 5.54 | 84.20 | 6.04 | |
| Depreciation Qtr | 2.50 | 1.48 | 2.66 | 1.86 | 1.83 | 1.70 | 1.69 | 1.67 | 1.67 | 1.40 | 1.18 | 1.15 | 1.13 | |
| Net Profit Qtr | 55.82 | 72.15 | 61.42 | 90.68 | 44.38 | 48.25 | 45.62 | 115.33 | -18.55 | 0.91 | 51.92 | 120.16 | 49.06 | |
| Basic EPS Qtr | 2.17 | 2.81 | 2.39 | 3.53 | 1.73 | 1.88 | 1.78 | 4.49 | -0.72 | 0.04 | 2.02 | 4.68 | 1.91 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 212.26 | 191.51 | 167.40 | 83.79 | 167.33 | |
| Operating Expenses Annual Cr | 100.62 | 86.91 | 64.29 | 62.45 | 70.65 | |
| Operating Profit Annual | 56.86 | 40.33 | 13.93 | 11.07 | 3.28 | |
| Operating Profit Margin Annual % | 26.79 | 21.06 | 8.32 | 13.21 | 1.96 | |
| Total Expenses Annual Cr | 109.57 | 94.10 | 69.54 | 66.75 | 74.16 | |
| EBIDT Annual Cr | 111.63 | 104.59 | 103.11 | 21.34 | 96.68 | |
| EBIDT Annual margin % | 52.59 | 54.62 | 61.60 | 25.47 | 57.78 | |
| Depreciation | 7.84 | 6.72 | 4.86 | 3.94 | 3.23 | |
| PAT Before ExtraOrdinary Items Annual Cr | 92.87 | 80.62 | 86.19 | 13.84 | 93.03 | |
| Net Profit Annual | 268.62 | 190.65 | 222.06 | 342.84 | 329.12 | |
| Basic EPS Annual | 10.46 | 7.42 | 8.65 | 13.35 | 12.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2185.56 | 2078.03 | 2496.58 | 2297.03 | 1418.04 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 52.89 | 42.74 | 67.60 | 52.52 | 6.88 | |
| Total Current Liabilities Annual Cr | 90.32 | 83.81 | 67.76 | 59.42 | 45.80 | |
| Total Capital Plus Liabilities Annual Cr | 2328.77 | 2204.58 | 2631.95 | 2408.96 | 1470.72 | |
| Fixed Assets Annual | 369.82 | 321.38 | 297.35 | 270.77 | 228.11 | |
| Total Non Current Assets Annual | 2191.38 | 2032.45 | 2488.63 | 2306.87 | 1307.90 | |
| Total Current Assets Annual | 137.39 | 172.14 | 143.32 | 102.09 | 162.82 | |
| Total Assets Annual | 2328.77 | 2204.58 | 2631.95 | 2408.96 | 1470.72 | |
| Contingent Liabilities plus Commitments Annual Cr | 92.93 | 145.66 | 119.83 | 155.81 | 130.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 22.69 | 38.85 | -17.75 | -2.18 | 6.17 | |
| Cash from Investing Activity Annual | 25.84 | 7.30 | 18.85 | -34.74 | 56.72 | |
| Cash from Financing Annual Activity | -48.19 | -46.39 | -5.82 | -15.36 | -6.05 | |
| Net Cash Flow Annual | 0.33 | -0.24 | -4.72 | -52.28 | 56.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 85.11 | 80.93 | 97.23 | 89.45 | 55.22 | |
| ROE Annual % | 12.29 | 9.17 | 8.89 | 14.92 | 23.20 | |
| ROCE Annual % | 4.63 | 4.61 | 3.83 | 0.74 | 6.55 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 70.88 | 82.20 | 131.82 | 29.03 | 130.77 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Chirayu Ramanbhai Amin | 3.24 | 88965614 | 0 | 0 |
| Malika Chirayu Amin | 2.99 | 88965615 | 0 | 0 |
| Pranav Chirayu Amin | 0.75 | 88965616 | 0 | 0 |
| Shaunak Chirayu Amin | 0.75 | 88965617 | 0 | 0 |
| Nirayu Limited | 63.06 | 88965625 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 1.1 | 88965657 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 05, 2024 | 2.4 | FINAL | Aug 05, 2024 | Equity Share |
| Aug 03, 2023 | 2.2 | FINAL | Aug 03, 2023 | Equity Share |
| Sep 12, 2022 | 1.8 | FINAL | Sep 13, 2022 | Equity Share |
| Jul 29, 2021 | 0.2 | FINAL | - | Equity Share |
| Jul 29, 2020 | 0.6 | FINAL | - | Equity Share |
| Sep 18, 2019 | 0.2 | FINAL | - | Equity Share |
| Jul 27, 2018 | 0.2 | FINAL | - | Equity Share |
| Jul 19, 2017 | 0.2 | FINAL | - | Equity Share |
| Aug 01, 2016 | 0.15 | FINAL | - | Equity Share |
| Aug 03, 2015 | 0.15 | FINAL | - | Equity Share |
| Aug 04, 2014 | 0.15 | FINAL | - | Equity Share |
| Aug 26, 2013 | 0.2 | FINAL | - | Equity Share |
| Jul 21, 2010 | 0.5 | FINAL | - | Equity Share |
| Jul 17, 2009 | 0.4 | FINAL | - | Equity Share |
| Jul 17, 2008 | 1.5 | FINAL | - | Equity Share |
| Aug 13, 2007 | 1 | FINAL | - | Equity Share |
| Aug 16, 2006 | 5 | FINAL | - | Equity Share |
| Aug 16, 2005 | 3 | FINAL | - | Equity Share |
| Jul 29, 2004 | 2 | FINAL | - | Equity Share |
| Aug 07, 2003 | 4.5 | FINAL | - | Equity Share |
| Aug 29, 2002 | - | FINAL | - | Equity Share |
| Jun 01, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Sep 26, 2006 | 10:2 | 2006-10-04 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| Aug 12, 2024 | Quarterly Results | - |
| May 13, 2024 | Audited Results & Final Dividend | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results | - |
| May 12, 2023 | Audited Results & Final Dividend | - |
| Feb 09, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 05, 2022 | Audited Results & Dividend | - |
| Feb 14, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 06, 2021 | Quarterly Results | - |
| May 11, 2021 | Audited Results & Final Dividend | - |
| Jan 28, 2021 | Quarterly Results | - |
| Nov 03, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| May 25, 2020 | Audited Results & Final Dividend | - |
| Jan 31, 2020 | Quarterly Results | - |
| Nov 11, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results & Final Dividend | - |
| May 15, 2019 | Audited Results | - |
| Jan 30, 2019 | Quarterly Results | - |
| Nov 03, 2018 | Quarterly Results & Scheme of Arrangement | - |
| Oct 30, 2018 | Quarterly Results | - |
| Aug 07, 2018 | Quarterly Results | - |
| May 17, 2018 | Audited Results & Dividend | - |
| Jan 23, 2018 | Quarterly Results & Buy Back of Shares | - |
| Oct 30, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 09, 2017 | Audited Results & Dividend | - |
| Jan 19, 2017 | Quarterly Results | - |
| Nov 11, 2016 | Quarterly Results | - |
| Aug 10, 2016 | Quarterly Results | - |
| Apr 26, 2016 | Audited Results & Dividend | - |
| Mar 28, 2016 | Appointment of Managing Director | - |
| Jan 28, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | - |
| Aug 12, 2015 | Quarterly Results | - |
| May 07, 2015 | Audited Results & Dividend | - |
| Jan 22, 2015 | Quarterly Results | - |
| Nov 05, 2014 | Quarterly Results | - |
| Aug 13, 2014 | Quarterly Results | - |
| May 06, 2014 | Audited Results & Dividend | - |
| Jan 30, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 09, 2013 | Bonus issue | To consider issue of Bonus shares. |
| Apr 24, 2013 | Audited Results & Dividend | - |
| Jan 31, 2013 | Quarterly Results | - |
| Nov 08, 2012 | Quarterly Results | - |
| Aug 13, 2012 | Quarterly Results | - |
| May 02, 2012 | Audited Results | - |
| Feb 14, 2012 | Quarterly Results | (Revised) |
| Oct 19, 2011 | Quarterly Results | - |
| Jul 26, 2011 | Quarterly Results | - |
| May 02, 2011 | Audited Results | - |
| Mar 31, 2011 | Others | To approve reconstitution of Board due to Demerger and considering other agenda items relating to Demerger including fixing of record date for ascertaining the eligibility of the members. |
| Jan 25, 2011 | Quarterly Results | (Revised) |
| Oct 19, 2010 | Quarterly Results | - |
| Jul 30, 2010 | Quarterly Results | - |
| Jun 29, 2010 | Demerger | The Board has approved the Demerger of Pharmaceutical Undertaking of the Co. & to merge the said Undertaking into Alembic Pharma Ltd., a WoS Co. of Alembic Ltd. wef appointed date i.e. April 01, 2010. |
| May 05, 2010 | Audited Results & Dividend | - |
| Mar 30, 2010 | Others | The Board has appointed CA Mr. Milin Mehta as Additional Independent Director of the Company. |
| Jan 25, 2010 | Quarterly Results | - |
| Oct 15, 2009 | Quarterly Results | - |
| Jul 28, 2009 | Quarterly Results | - |
| May 08, 2009 | Audited Results, Dividend & Others | For amendment in Object Clause of the Memorandum of Association of the Company u/s 17 of the Companies Act, 1956 through the process of postal ballot u/s 192A of the Companies Act, 1956. |
| Jan 28, 2009 | Quarterly Results | - |
| Nov 14, 2008 | Buy Back of Shares | To consider the buy back for an amount not exceeding Rs 3,300 lacs, constituting 9.69% of the paid-up capital, free reserves of the Co. & the maximum buy back price is Rs 55/- per equity share. |
| Oct 20, 2008 | Quarterly Results | - |
| Jul 28, 2008 | Quarterly Results | - |
| Apr 25, 2008 | Audited Results & Dividend | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 17, 2007 | Quarterly Results | - |
| Jul 18, 2007 | Quarterly Results | - |
| May 22, 2007 | Audited Results & Dividend | - |
| Jan 31, 2007 | Acquisition | To aquire Domestic Non-Oncology Formulations Business comprising the brands, trademarks, copyrights, designs, of M/s. Dabur Pharma Ltd, New Delhi. |
| Jan 17, 2007 | Quarterly Results | - |
| Oct 17, 2006 | Quarterly Results | - |
| Jul 18, 2006 | Quarterly Results & Stock Split | - |
| Apr 26, 2006 | Accounts & Dividend | - |
| Jan 20, 2006 | Quarterly Results | - |
| Oct 26, 2005 | Quarterly Results | - |
| Jul 20, 2005 | Quarterly Results | - |
| Jul 04, 2005 | Accounts & Dividend | - |
| Apr 29, 2005 | Quarterly Results | - |
| Jan 24, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Preferential Issue of shares | to consider preferential issue of equity shares to the promoter group at the price not below the price to be determined as per the SEBI guidelines. |
| Jul 22, 2004 | Quarterly Results | - |
| May 07, 2004 | Dividend & Accounts | - |
| Mar 30, 2004 | Others | The Board has allotted the Bonus Shares. |
| Feb 12, 2004 | Bonus issue | - |
| Jan 23, 2004 | Quarterly Results | - |
| Dec 10, 2003 | Others | To approve offer document for 14,71,742 equity shares on rights basis at a issue price of Rs.220/- per share. |
| Oct 23, 2003 | Quarterly Results | - |
| Sep 01, 2003 | Right Issue of Equity Shares | - |
| Jul 24, 2003 | Quarterly Results | - |
| Jun 28, 2003 | Dividend & Accounts | - |
| Mar 15, 2003 | Others | Issue and allot upto 1,45,000 Equity shares of Rs. 10/- each credited as fully paid up in the share capital of the Company as per the Scheme of De-merger approved by all the concerned authorities. |
| Jan 25, 2003 | Quarterly Results | - |
| Oct 24, 2002 | Quarterly Results | - |
| Jul 24, 2002 | Quarterly Results | - |
| Jun 27, 2002 | Accounts & Dividend | - |
| Mar 30, 2002 | Others | Issue of 144945 equity shares to the shareholders of M/s.Darshak Ltd. as per the scheme approved |
| Jan 25, 2002 | Quarterly Results | - |
| Oct 28, 2001 | Quarterly Results | (Revised) |
| Aug 18, 2001 | Others | Issue of equity shares to Darshak Ltd. pursuant to Demerger of its Bulk Drug Division. |
| Jul 27, 2001 | Quarterly Results | - |
| Apr 25, 2001 | Qtr Results, Accounts & Merger | Merger / Amalgamation of bulk drug unit of Darshak Ltd., and to consider exchange ratio of equity shares (announced on 18/04/2001) |
| Jan 24, 2001 | Quarterly Results & Others | Taking over of bulk drugs manufacturing unit of M/s. Darshak Ltd., Gujarat (Announced on 16/01/2001) |
| Oct 24, 2000 | Quarterly Results | - |
| Jul 29, 2000 | Quarterly Results | - |
| Apr 20, 2000 | Quarterly Results and Accounts | - |
| Mar 30, 2000 | Interim Dividend | - |
| Jan 20, 2000 | Quarterly Results | - |
| Oct 21, 1999 | Quarterly Results | To prepay - 13.5% Red.NC Pref.Shares of Rs.100 & pay dividend on such share |
| Jul 19, 1999 | Quarterly Results | - |
| Apr 28, 1999 | Quarterly Results | - |
| Apr 06, 1999 | Accounts & Dividend | - |
| Jan 28, 1999 | Redemption & Interim Dividend of P Share | - |
| Jan 27, 1999 | Quarterly Results | - |
| Oct 13, 1998 | Quarterly Results | - |
| Jul 23, 1998 | Half Yearly Results & Quaterly Results | - |
| Apr 23, 1998 | Pref.Basis | - |
| Mar 23, 1998 | Accounts & Dividend | - |
| Aug 23, 1997 | Half Yearly Results | - |
| Mar 29, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Sep 27, 2013 | 1:1 | 2013-09-30 |
| Mar 25, 2004 | 2:1 | 2004-03-27 |
06 Sep 2024
ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 6th September, 2024 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate to the registered shareholder(s).
04 Sep 2024
ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 4th September, 2024 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate(s) and issuance of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s).
29 Aug 2024
ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 29th August, 2024, received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of duplicate share certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s).
29 Aug 2024
ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 29th August, 2024 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s).
20 Aug 2024
ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 20th August, 2024 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s).
13 Aug 2024
ALEMBIC LTD. - 506235 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith paper cuttings of Extract of Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2024, published in Indian Express (English Edition) and Financial Express (Gujarati Edition - vernacular language) on 13th August, 2024.
13 Aug 2024
ALEMBIC LTD. - 506235 - Announcement under Regulation 30 (LODR)-Change in Directorate
Please find enclosed herewith the intimation for re-appointment of Mrs. Rati Desai as an Independent Director of the Company w.e.f 13th August, 2024.
12 Aug 2024
ALEMBIC LTD. - 506235 - Proceedings Of The 117Th Annual General Meeting Held On 12Th August, 2024
Please find enclosed herewith proceedings of the 117th Annual General Meeting of the Company held on 12th August, 2024
12 Aug 2024
ALEMBIC LTD. - 506235 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find enclosed herewith scrutinizers report.
